Electromechanical uncoupling in a molluscan muscle examined by the sucrose gap technique. The effect of calcium antagonist and agonist agents.
Membrane potential and tension of Busycon radular protractor muscles were studied by sucrose gap methods. Excitation-contraction (EC) coupling was examined in response to acetylcholine (ACh) and high K which depolarized the fibres and induced tension, but without action potential firing. Potassium depolarization did not follow predictions expected from the Nernst equation at low and very high K levels, and maximum tension was found at about 100 mM K. EC coupling was very sensitive to [Ca]0. Ca-free media eliminated K- and ACh-induced tension but with normal depolarization, showing full electromechanical uncoupling. Ionophore A23187 enhanced K- and ACh-induced responses and X-537A enhanced ACh responses, demonstrating acute dependence of activation on [Ca]0 in this muscle. The calcium antagonists nifedipine and nisoldipine reduced tension in the muscle only at very high concentrations, and both agents slightly reduced K- and ACh-induced depolarization. Verapamil reduced K- and ACh-induced tension but paradoxically it enhanced the depolarizing actions of these agents leading to electromechanical uncoupling. Abscisic acid (ABA) enhanced ACh- and K-induced tension and simultaneously enhanced their depolarizing actions. Ionophores and ABA appear to enhance calcium influx which may secondarily influence sodium influx. Calcium antagonists have no consistent actions on this muscle, suggesting that calcium channel activity of the radular protractor may be different from that seen in mammalian visceral muscles.
Huddart
H
H
Department of Zoology, University of Rhode Island, Kingston, 02881.
Hill
R B
RB
D000818:Animals; D001696:Biomechanical Phenomena; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002120:Calcium Channel Agonists / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004594:Electrophysiology / Q000379:methods; D007832:Lasalocid / Q000494:pharmacology; D008974:Mollusca / Q000502:physiology*; D013395:Sucrose
D002120:Calcium Channel Agonists; D002121:Calcium Channel Blockers; D000001:Calcimycin; D013395:Sucrose; D002118:Calcium; D007832:Lasalocid